Viela Bio Funding: $300M Raised, Series B (2019)

Viela Bio funding overview

Viela Bio is based in Gaithersburg, Maryland. Viela Bio has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in June 2019. The round record for Viela Bio runs through 2019; nothing later has been disclosed. Investors on record include HBM Healthcare Investments, Viking Global Investors, Cormorant Asset Management, Terra Magnum Capital Partners, Goldman Sachs, Barer & Son Capital and 1 others. 7 distinct backers are named across the disclosed rounds.

Viela Bio at a glance

Total raised: $300M
Latest round: Series B
Latest round date: June 2019
Headquarters: Gaithersburg, Maryland
Notable investors: HBM Healthcare Investments, Viking Global Investors, Cormorant Asset Management, Terra Magnum Capital Partners, Goldman Sachs, Barer & Son Capital, Temasek

Frequently asked about Viela Bio funding

How much has Viela Bio raised?: Viela Bio has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Viela Bio?: HBM Healthcare Investments, Viking Global Investors, Cormorant Asset Management, Terra Magnum Capital Partners, Goldman Sachs, Barer & Son Capital are named among the investors backing Viela Bio.
What was the latest Viela Bio funding round?: The most recent disclosed round is a Series B, announced in June 2019.
Where is Viela Bio based?: Viela Bio is based in Gaithersburg, Maryland.
When did Viela Bio last raise?: The last disclosed Viela Bio round closed in June 2019 at Series B.

Viela Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Gaithersburg below to benchmark round size and investor mix.

Viela Bio Funding: $300M Raised, Series B (2019)

Viela Bio funding overview

Viela Bio at a glance

Frequently asked about Viela Bio funding

Companies related to Viela Bio (24)

Browse related funding lists (7)